 Mitacs Accelerate grant expected to fund 50 of research costs evaluating ART26.12 as a potential treatment for anxiety disorders Mitacs Accelerate grant expected to fund 50 of research costs evaluating ART26.12 as a potential treatment for anxiety disorders 